Categorized | Health, Holiday, Lower Pottsgrove

Eight Blood Drives Scheduled For Post-Holiday Need

Can you spare a pint?

POTTSTOWN PA – The emergency need for blood products always seems greatest around the holidays. That’s why, following the Independence Day respite, eight blood collection drives begin next Wednesday (July 6, 2011) and continue through July 17 in Lower Pottsgrove, Pottstown, North Coventry, Parker Ford, Phoenixville and Douglassville PA, conducted by the Miller-Keystone Blood Center.

Drives are scheduled for:

  • Wednesday (July 6) from 7-10 a.m. at Verizon Business, 51 Robinson St., Pottstown PA;
  • Wednesday (July 6) from 12:30-5:30 p.m. at Pottstown Medical Specialists, 1591 Medical Dr., Lower Pottsgrove (PA) Township PA;
  • July 9 (Saturday) from 6-9 p.m. at Norco Fire Company, 144 W. Schuylkill Rd., Pottstown PA;
  • July 9 (Saturday) from 9 a.m. to 12:30 p.m. at Parker Ford Church, 20 Rinehart Rd., Pottstown;
  • July 13 (Wednesday) from 4:15-6:30 p.m. at Stepping Stone Education Center, 400 Franklin Ave., Phoenixville PA;
  • July 13 (Wednesday) from 3-7 p.m. by the Douglassville community at Daniel Boone Middle School, 1845 Weavertown Rd., Douglassville PA;
  • July 15 (Friday) from 8 a.m. to 12:40 p.m. at Pottstown Borough Hall, 100 High St., Pottstown PA; and
  • July 17 (Sunday) from Non to 3 p.m. at Dairy Queen, 1467 E. High St., Pottstown PA.

Appointments are required and may be made by calling the blood bank at 610-926-6060.

Photo from Clipart.com

Share

One Response to “Eight Blood Drives Scheduled For Post-Holiday Need”

Trackbacks/Pingbacks

  1. [...] Eight Blood Drives Scheduled For Post-Holiday Need Eight blood collection drives begin next Wednesday and continue through July 17 in Lower Pottsgrove, Pottstown, North Coventry, Parkerford, Phoenixville and Douglassville. [...]


From Our Sponsors

RSS Health News

  • Death rate drops among Americans with diabetes -CDC May 22, 2012
    ATLANTA (Reuters) - A 40 percent decline in the death rate of diabetic American adults from heart disease and strokes is a sign that patients are taking better care of themselves and receiving improved treatment, according to a government study released on Tuesday. […]
  • Mom's excess pounds key in newborn weight May 22, 2012
    NEW YORK (Reuters Health) - For at least some moms-to-be, it's extra body fat -- and not blood sugar levels -- that may be key to their risk of having a big baby, a study published Tuesday suggests. […]
  • Scientists turn skin cells into beating heart muscle May 22, 2012
    LONDON (Reuters) - Scientists have for the first time succeeded in taking skin cells from patients with heart failure and transforming them into healthy, beating heart tissue that could one day be used to treat the condition. […]
  • U.S. says drug abuse needs treatment, not just jail May 22, 2012
    LONDON (Reuters) - The United States sees drug abuse as a public health problem as much as a crime issue and is seeking to learn from countries in Europe and elsewhere about how to treat addiction as a disease, Barack Obama's drugs policy chief said on Tuesday. […]
  • Folic acid tied to lower child cancer risks May 22, 2012
    NEW YORK (Reuters Health) - Rates of two rare childhood cancers declined after the U.S. began requiring grain products to be fortified with the B vitamin folic acid, a new study finds. […]
  • Many babies with development delays may go untreated May 22, 2012
    NEW YORK (Reuters Health) - About one out of every three infants who scores well below average on a test of developmental skills -- and is therefore considered at a high risk of having delays -- does not get referred to early intervention services, according to a new study. […]
  • Exercise tied to lower risk of psoriasis: study May 22, 2012
    NEW YORK (Reuters Health) - Results from a large U.S. study suggest women who regularly exercise vigorously, including runners and aerobics buffs, may be less likely to get psoriasis than less-active women. […]
  • Takeda drug impresses in ulcerative colitis study May 22, 2012
    (Reuters) - More than 40 percent of patients with moderate to severe ulcerative colitis achieved clinical remission from the debilitating condition after a year of taking an experimental drug developed by Japan's Takeda Pharmaceutical Co, according to data from a pivotal late-stage trial. […]
  • FDA staff shoots down Pfizer rare disease drug May 22, 2012
    WASHINGTON (Reuters) - Drug reviewers on Tuesday recommended rejecting a Pfizer Inc drug because the data did not prove it worked well in treating a rare neurodegenerative disease. […]
  • Eli Lilly's diabetes drug meets mid-stage trial goal May 22, 2012
    (Reuters) - Drugmaker Eli Lilly and Co's experimental drug to treat type 2 diabetes met the main goal of a mid-stage trial to test its effect on blood pressure and heart rate. […]